Rexahn Pharmaceuticals Announces Supinoxin™ Poster Presentations at the 2016 Gastrointestinal Cancers Symposium Jan 25, 2016
New Preclinical Data for Supinoxin™ Show Oral Administration Produces Clinically Meaningful Tumor Growth Inhibition Jan 12, 2016
Rexahn Pharmaceuticals’ Archexin® Shows Dose-Dependent Tumor Reduction in a Phase IIa Clinical Study Jan 11, 2016
Rexahn Pharmaceuticals Announces New Data for Supinoxin™ Showing Potent Tumor Growth Inhibition Dec 14, 2015
Rexahn Pharmaceuticals to Present at the Stifel 2015 Healthcare Conference on November 18, 2015 Nov 11, 2015
Rexahn Pharmaceuticals Reports Interim Clinical Data for Archexin® at the 14th International Kidney Cancer Symposium Nov 5, 2015
Rexahn Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update Nov 3, 2015